ALZAMEND NEURO, INC. Property, Plant and Equipment
ALZAMEND NEURO, INC. (ALZN) had Property, Plant and Equipment of $287.18 thousand as of 2026-07-31, per its 10-Q filed 2026-09-10.
Financial Statements › Balance Sheet › Assets
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-09-10
- 2026-07-31: Property, Plant and Equipment, Net $287.18K.
- 2026-04-30: Property, Plant and Equipment, Net $314.87K.
- 2026-01-31: Property, Plant and Equipment, Net $342.55K.
- 2025-10-31: Property, Plant and Equipment, Net $370.24K.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-07-31 | $287.18K 10-Q · filed 2026-09-10 |
| 2026-04-30 | $314.87K 10-Q · filed 2026-09-10 |
| 2026-01-31 | $342.55K 10-Q · filed 2026-03-11 |
| 2025-10-31 | $370.24K 10-Q · filed 2025-12-09 |
| 2025-07-31 | $397.92K 10-Q · filed 2025-09-10 |
| 2025-04-30 | $425.61K 10-K · filed 2026-07-22 |
| 2025-01-31 | $228.29K 10-Q · filed 2025-03-10 |
| 2024-10-31 | $240.98K 10-Q · filed 2024-12-11 |
| 2024-07-31 | $253.66K 10-Q · filed 2024-09-11 |
| 2024-04-30 | $176.35K 10-K · filed 2025-07-22 |
| 2024-01-31 | $189.03K 10-Q · filed 2024-03-25 |
| 2023-10-31 | $201.72K 10-Q · filed 2023-12-15 |
| 2023-07-31 | $214.40K 10-Q · filed 2023-09-13 |
| 2023-04-30 | $79.84K 10-K · filed 2024-07-30 |
| 2023-01-31 | $85.17K 10-Q · filed 2023-03-15 |
| 2022-10-31 | $90.49K 10-Q · filed 2022-12-12 |
| 2022-07-31 | $95.81K 10-Q · filed 2022-09-13 |
| 2022-04-30 | $102.91K 10-K · filed 2023-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |